Xeris Biopharma Holdings, Inc. (XERS) SEC filings
XERS SEC filings moved a median of +0.18% by the close. XERS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the XERS overview →
57 measured XERS SEC filing events.
Where these XERS SEC filings landedvs 57 measured XERS SEC filing reactions
| Middle 50% of XERS SEC filing reactions | -2.94% to +2.17% |
|---|---|
| Median reaction (to close) | +0.18% |
| Measured reactions | 57 |
Point-in-time · zero look-ahead
Half of the 57 XERS SEC filing events with a measured close landed between -2.94% and +2.17%; 51% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Xeris Biopharma Holdings For: Oct 13 | SEC filing · Form 8-K | +0.59% | -3.08% | |
| Form 8-K Xeris Biopharma Holdings For: Sep 09 | SEC filing · Form 8-K | -0.47% | -8.54% | |
| Form 10-Q Xeris Biopharma Holdings For: Jun 30 | SEC filing · Form 10-Q | +2.09% | +6.73% | |
| Form 8-K Xeris Biopharma Holdings For: Aug 06 | SEC filing · Form 8-K | +0.42% | +2.36% | |
| Form 8-K Xeris Biopharma Holdings For: Jul 15 | SEC filing · Form 8-K | +0.68% | -2.27% | |
| Form 8-K Xeris Biopharma Holdings For: Jun 29 | SEC filing · Form 8-K | -0.50% | +0.00% | |
| Form 8-K Xeris Biopharma Holdings For: Jun 10 | SEC filing · Form 8-K | -0.75% | +3.43% | |
| Form 8-K Xeris Biopharma Holdings For: Jun 04 | SEC filing · Form 8-K | +0.74% | +0.32% | |
| Form 10-Q Xeris Biopharma Holdings For: Mar 31 | SEC filing · Form 10-Q | -1.22% | -0.61% | |
| Form 8-K Xeris Biopharma Holdings For: May 07 | SEC filing · Form 8-K | -0.45% | -1.04% | |
| Form ARS Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form ARS | -0.17% | +1.85% | |
| Form DEF 14A Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form DEF | -0.17% | +1.85% | |
| Form DEFA14A Xeris Biopharma Holdings | SEC filing · Form DEFA14A | -0.17% | +1.85% | |
| Form 8-K Xeris Biopharma Holdings For: Apr 20 | SEC filing · Form 8-K | -0.68% | +1.85% | |
| Form 10-K Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form 10-K | +0.95% | +2.24% | |
| Form 8-K Xeris Biopharma Holdings For: Mar 02 | SEC filing · Form 8-K | -1.70% | -14.97% | |
| Form S-8 Xeris Biopharma Holdings | SEC filing · Form S-8 | +0.95% | +2.24% | |
| Form 8-K Xeris Biopharma Holdings For: Feb 26 | SEC filing · Form 8-K | -0.32% | -5.99% | |
| Form 8-K Xeris Biopharma Holdings For: Jan 08 | SEC filing · Form 8-K | +0.26% | +6.69% | |
| Form 8-K Xeris Biopharma Holdings For: Dec 01 | SEC filing · Form 8-K | +1.13% | -1.70% | |
| Form 10-Q Xeris Biopharma Holdings For: Sep 30 | SEC filing · Form 10-Q | +0.66% | -1.33% | |
| Form 8-K Xeris Biopharma Holdings For: Nov 06 | SEC filing · Form 8-K | -0.12% | -8.21% | |
| Form 10-Q Xeris Biopharma Holdings For: Jun 30 | SEC filing · Form 10-Q | +1.28% | +2.86% | |
| Form 8-K Xeris Biopharma Holdings For: Aug 07 | SEC filing · Form 8-K | -5.15% | -2.94% | |
| Form 8-K Xeris Biopharma Holdings For: Jun 04 | SEC filing · Form 8-K | -1.33% | +0.23% | |
| Form 8-K Xeris Biopharma Holdings For: Jun 03 | SEC filing · Form 8-K | -3.48% | -7.55% | |
| Form EFFECT Xeris Biopharma Holdings | SEC filing · Form EFFECT | -0.33% | -6.45% | |
| Form 10-Q Xeris Biopharma Holdings For: Mar 31 | SEC filing · Form 10-Q | -0.96% | -3.47% | |
| Form 8-K Xeris Biopharma Holdings For: May 08 | SEC filing · Form 8-K | +2.26% | +16.74% | |
| Form ARS Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form ARS | +0.96% | +3.13% | |
| Form DEF 14A Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form DEF | +0.96% | +3.13% | |
| Form DEFA14A Xeris Biopharma Holdings | SEC filing · Form DEFA14A | +0.96% | +3.13% | |
| Form 8-K Xeris Biopharma Holdings For: Mar 28 | SEC filing · Form 8-K | -0.91% | +0.18% | |
| Form 10-K Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form 10-K | +1.21% | +2.17% | |
| Form 8-K Xeris Biopharma Holdings For: Mar 06 | SEC filing · Form 8-K | -4.11% | -0.24% | |
| Form S-3 Xeris Biopharma Holdings | SEC filing · Form S-3 | +1.21% | +2.17% | |
| Form S-8 Xeris Biopharma Holdings | SEC filing · Form S-8 | +1.21% | +2.17% | |
| Form 8-K Xeris Biopharma Holdings For: Feb 24 | SEC filing · Form 8-K | +1.74% | +0.80% | |
| Form 8-K Xeris Biopharma Holdings For: Jan 10 | SEC filing · Form 8-K | -1.78% | +0.89% | |
| Form 10-Q Xeris Biopharma Holdings For: Sep 30 | SEC filing · Form 10-Q | -4.40% | -3.81% | |
| Form 8-K Xeris Biopharma Holdings For: Nov 08 | SEC filing · Form 8-K | -6.47% | +2.06% | |
| Form 10-Q Xeris Biopharma Holdings For: Jun 30 | SEC filing · Form 10-Q | +4.89% | +3.11% | |
| Form 8-K Xeris Biopharma Holdings For: Aug 08 | SEC filing · Form 8-K | +1.36% | -0.45% | |
| Form S-8 Xeris Biopharma Holdings | SEC filing · Form S-8 | +4.89% | +3.11% | |
| Form 8-K Xeris Biopharma Holdings For: Aug 01 | SEC filing · Form 8-K | -1.24% | +0.91% | |
| Form 8-K Xeris Biopharma Holdings For: Jul 07 | SEC filing · Form 8-K | +1.38% | -2.29% | |
| Form 8-K Xeris Biopharma Holdings For: Jun 05 | SEC filing · Form 8-K | -0.83% | -2.08% | |
| Form 10-Q Xeris Biopharma Holdings For: Mar 31 | SEC filing · Form 10-Q | -1.83% | -7.85% | |
| Form 8-K Xeris Biopharma Holdings For: May 09 | SEC filing · Form 8-K | -3.78% | +1.62% | |
| Form ARS Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form ARS | +0.84% | -1.12% | |
| Form DEF 14A Xeris Biopharma Holdings For: Jun 05 | SEC filing · Form DEF | +0.84% | -1.12% | |
| Form DEFA14A Xeris Biopharma Holdings | SEC filing · Form DEFA14A | +0.84% | -1.12% | |
| Form 10-K Xeris Biopharma Holdings For: Dec 31 | SEC filing · Form 10-K | -2.76% | -3.56% | |
| Form 8-K Xeris Biopharma Holdings For: Mar 05 | SEC filing · Form 8-K | -6.09% | -18.42% | |
| Form 8-K Xeris Biopharma Holdings For: Jan 04 | SEC filing · Form 8-K | -2.30% | +5.86% | |
| Form 10-Q Xeris Biopharma Holdings For: Sep 30 | SEC filing · Form 10-Q | -5.88% | -9.89% | |
| Form 8-K Xeris Biopharma Holdings For: Nov 09 | SEC filing · Form 8-K | -7.25% | -12.80% |
Keep exploring
More XERS: earnings → · analyst actions → · XERS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | 256 | +0.04% | 57% |
| Prothena Corporation plc - Ordinary Shares (PRTA) | 256 | -0.04% | 49% |
| Cerus Corporation (CERS) | 255 | +0.09% | 52% |
| Avalon GloboCare Corp. (AVCO) | 254 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.